This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Pharma/Biotech GTN Summit
November 18-20, 2024
W Philadelphia HotelPhiladelphia, PA

Jennifer Winterhalter
Vice President, Revenue Management at Amneal Pharmaceuticals


Jennifer Winterhalter is the Vice President, Revenue Management at Amneal Pharmaceuticals in Bridgewater NJ. She oversees all Gross to Net activities including month-end close accounting and reporting, Government Pricing, and adjudication of all Chargebacks, Returns, Rebates, Admin Fees, etc. Jennifer has a BA in Accounting from Rutgers University and an Executive MBA from Pace University, along with over 30 years’ experience in Corporate Finance; 17 years of which is in the pharmaceutical sector. Her focus had been primarily Generics until a 2018 acquisition introduced a Specialty portfolio. Amneal has also joined the Biosimilar space, launching three products since late 2022.

Jennifer lives in Bergen County NJ with her husband of 30 years and has three children, 26, 23 & 22. She enjoys reading and doing puzzles at her vacation home in the Catskills. Jennifer is the Treasurer of a non-profit called Family Reach Foundation, which is dedicated to removing the financial barriers standing between a cancer patient and their treatment.

Agenda Sessions

  • Panel Discussion: Examining the similarities and differences for GTN activities for pharma, biotechs and generics companies